These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


207 related items for PubMed ID: 7853854

  • 1. Detection of 17p loss in gastric carcinoma using polymerase chain reaction.
    Kim CJ, Kim WH, Kim CW, Lee JB, Lee CK, Kim YL.
    Lab Invest; 1995 Feb; 72(2):232-6. PubMed ID: 7853854
    [Abstract] [Full Text] [Related]

  • 2. Loss of heterozygosity and p53 gene mutations in breast cancer.
    Deng G, Chen LC, Schott DR, Thor A, Bhargava V, Ljung BM, Chew K, Smith HS.
    Cancer Res; 1994 Jan 15; 54(2):499-505. PubMed ID: 8275488
    [Abstract] [Full Text] [Related]

  • 3. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection.
    Kim JW, Lee CG, Han SM, Kim KS, Kim JO, Lee JM, Kim IK, Namkoong SE.
    Gynecol Oncol; 1997 Nov 15; 67(2):215-21. PubMed ID: 9367711
    [Abstract] [Full Text] [Related]

  • 4. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
    Li JT, Fu L, Xia JC, Feng BJ, Mai SJ, Yu XJ, Huang LX, Feng QS, Pan ZZ, Zhan YQ.
    Ai Zheng; 2005 Nov 15; 24(11):1306-11. PubMed ID: 16552953
    [Abstract] [Full Text] [Related]

  • 5. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF, Tang PZ, Cheng SJ.
    Ai Zheng; 2003 May 15; 22(5):452-7. PubMed ID: 12753701
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Frequent loss of heterozygosity at the DCC locus in gastric cancer.
    Uchino S, Tsuda H, Noguchi M, Yokota J, Terada M, Saito T, Kobayashi M, Sugimura T, Hirohashi S.
    Cancer Res; 1992 Jun 01; 52(11):3099-102. PubMed ID: 1591722
    [Abstract] [Full Text] [Related]

  • 8. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
    Ittmann MM.
    Prostate; 1996 May 01; 28(5):275-81. PubMed ID: 8610052
    [Abstract] [Full Text] [Related]

  • 9. Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization.
    Kobayashi M, Kawashima A, Mai M, Ooi A.
    Am J Pathol; 1996 Nov 01; 149(5):1575-84. PubMed ID: 8909247
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
    Sakamoto T, Nomura N, Mori H, Wake N.
    Gynecol Oncol; 1996 Nov 01; 63(2):173-9. PubMed ID: 8910623
    [Abstract] [Full Text] [Related]

  • 13. Loss of heterozygosity and overexpression of the p53 gene in ovarian carcinoma.
    Frank TS, Bartos RE, Haefner HK, Roberts JA, Wilson MD, Hubbell GP.
    Mod Pathol; 1994 Jan 01; 7(1):3-8. PubMed ID: 7909153
    [Abstract] [Full Text] [Related]

  • 14. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P.
    Cancer Res; 1994 Aug 01; 54(15):4200-6. PubMed ID: 8033152
    [Abstract] [Full Text] [Related]

  • 15. Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus.
    Okamoto A, Sameshima Y, Yamada Y, Teshima S, Terashima Y, Terada M, Yokota J.
    Cancer Res; 1991 Oct 15; 51(20):5632-5. PubMed ID: 1913680
    [Abstract] [Full Text] [Related]

  • 16. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
    Frankel RH, Bayona W, Koslow M, Newcomb EW.
    Cancer Res; 1992 Mar 15; 52(6):1427-33. PubMed ID: 1347252
    [Abstract] [Full Text] [Related]

  • 17. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
    Shao J, Li Y, Li H, Wu Q, Hou J, Liew C.
    Chin Med J (Engl); 2000 Sep 15; 113(9):817-22. PubMed ID: 11776078
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
    Wagata T, Shibagaki I, Imamura M, Shimada Y, Toguchida J, Yandell DW, Ikenaga M, Tobe T, Ishizaki K.
    Cancer Res; 1993 Feb 15; 53(4):846-50. PubMed ID: 8094033
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.